Optibrium releases 3D ligand-based design module for StarDrop Drug Discovery Software
The innovative predictive methods support virtual screening and compound design in the absence of 3D structure data
The innovative predictive methods support virtual screening and compound design in the absence of 3D structure data
The Thermo Scientific TSQ Plus triple quadrupole mass spectrometer portfolio meets productivity demands through improved speed and sensitivity
The Thermo Scientific Vanquish Neo UHPLC System and Thermo Scientific PepMap Neo Columns enable consistent, high-quality results in high-sensitivity LC-MS workflows
From pipettes to incubators, DNA kits and more, we reveal the latest products to earn these coveted awards based on exceptional reviewer feedback
Watch this on-demand webinar to explore a complete workflow for the development of targeted biomarker measurements for precision medicine
Opaganib demonstrated strong inhibition of COVID-19 Delta variant in a human bronchial epithelial cell model
In this guest article by RayBiotech Life, learn how ELISA and pseudoviruses enable COVID-19 drug development
The CDx approval expands clinical utility of Oncomine Dx Target Test to identify candidates for TIBSOVO
Fusion Antibodies and Eurofins Discovery sign co-marketing agreement to support timely and cost-effective development of innovative products for the benefit of global healthcare.
R&D manager Yahya Nuruddeen supervises multiple research teams. Here, he explains how reviews have helped him make the right decision for their laboratories
PD-L1 IHC 22C3 pharmDx can now be used as an aid to identify esophageal cancer patients for treatment with KEYTRUDA (pembrolizumab)
Patients with underlying heart problems are more than four times as likely to die from COVID-19
In this compilation of top resources, explore the latest chromatographic techniques and technologies
This week, explore topics ranging from checkpoint inhibitor therapies to TIRF microscopy and automated liquid chromatography
Johan Engström, Senior Scientist at Gyros Protein Technologies, discusses the challenges of measuring high-affinity interactions of ligands in cancer immunotherapy
Will enable cancer researchers to accelerate identification and optimization of therapeutic leads by better decoding KRAS mutations present in 25% of tumors
From tackling COVID-19 variants to therapeutic discovery, novel organoids and more, advance your assay research with these exclusive interviews and free resources
Dr. Erik Tillman shares his virtual company’s quest to find an effective new life-changing treatment for non-alcoholic steatohepatitis
Both multi-mode readers feature a modular architecture so that researchers may purchase based on their immediate needs and upgrade the unit
The Synthetic Brain Project is using AI models powered by the Cambridge-1 supercomputer